Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MMP12 | P39900 | 2/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6079838 | 0.92 | MMP2 (0.31) | MMP2MMP12 | |
| SCHEMBL6080053 | 0.91 | MMP2 (0.39) | MMP2MMP12EGLN1 | |
| SCHEMBL6080097 | 0.88 | MMP2 (0.37) | MMP2MMP12EGLN1XDH | |
| SCHEMBL6080114 | 0.85 | FFAR1 (0.38) | EGLN1XDH | |
| SCHEMBL6079888 | 0.80 | MMP2 (0.40) | MMP2MMP12EGLN1XDH | |
| SCHEMBL6080217 | 0.77 | KDM4E (0.35) | — | |
| SCHEMBL6598552 | 0.76 | XDH (0.42) | MMP2MMP12XDH | |
| SCHEMBL6595349 | 0.75 | MMP2 (0.43) | MMP2MMP12XDH | |
| SCHEMBL6596772 | 0.73 | MMP2 (0.42) | MMP2MMP12EGLN1XDH | |
| SCHEMBL6596273 | 0.73 | XDH (0.44) | XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NEURO3D (FR) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NQO1, NQO2, RECQL | MMP2 4090/4885MMP12 4456/4885EGLN1 1893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.